Immediate Impact
2 by Nobel laureates 3 from Science/Nature 62 standout
Citing Papers
Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Donna M. Graham being referenced
Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase II LEAP-005 study.
2021
Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Donna M. Graham | 421 | 227 | 112 | 200 | 63 | 1.0k | |
| António Galán de Mera | 394 | 200 | 129 | 137 | 140 | 1.4k | |
| Oskar Hagberg | 349 | 157 | 40 | 192 | 65 | 1.2k | |
| Thomas L. Kennedy | 171 | 186 | 54 | 147 | 46 | 1.1k | |
| Jiang Zhu | 265 | 253 | 109 | 304 | 93 | 1.0k | |
| Hirofumi Michimae | 310 | 193 | 59 | 144 | 64 | 1.2k | |
| Cristina López | 140 | 84 | 53 | 265 | 43 | 880 | |
| P. De Angelis | 318 | 54 | 177 | 429 | 36 | 1.2k | |
| Luca Marini | 391 | 282 | 78 | 184 | 45 | 1.2k | |
| David P. Turner | 205 | 240 | 272 | 673 | 65 | 1.3k | |
| David L. Perkins | 106 | 34 | 125 | 204 | 31 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...